| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 06/30/1998 | US5773620 Quaternary ammonium salts of aromatic amine compounds, their preparation and pharmaceutical compositions in which they are present |
| 06/30/1998 | US5773612 Indol-2-one derivatives |
| 06/30/1998 | US5773530 Pyrazolopyridine adenosine antagonists |
| 06/30/1998 | US5773448 Nervous system disorders |
| 06/30/1998 | US5773440 Antiinflammatory agent |
| 06/30/1998 | US5773436 Use of serotonin antagonists for treating fibromyalgia |
| 06/30/1998 | US5773000 Therapeutic treatment of clostridium difficile associated diseases |
| 06/30/1998 | US5772999 Method of preventing, countering, or reducing NSAID-induced gastrointestinal damage by administering milk or egg products from hyperimmunized animals |
| 06/30/1998 | CA2139947C Calcium channel blocking polypeptide from agelenopsis aperta |
| 06/25/1998 | WO1998027108A2 New amide compounds and their use as nitric oxide synthase inhibitors |
| 06/25/1998 | WO1998026787A1 Prebiotics and probiotics |
| 06/25/1998 | WO1998026779A1 The use of 7-(2-oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the treatment of helicobacter pylori infections and associated gastroduodenal diseases |
| 06/25/1998 | WO1998026768A2 Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)-quinolone carboxylic acid and naphthyridone carboxylic acid derivatives for treating helicobacter pylori infections and the gastroduodenal diseases associated therewith |
| 06/25/1998 | WO1998022101A3 Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents |
| 06/25/1998 | WO1998019649A3 Methods and compositions for inhibition of angiogenesis |
| 06/25/1998 | WO1998016504A3 SULFONAMIDE SUBSTITUTED ASPARTIC ACID INTERLEUKIN-1β CONVERTING ENZYME INHIBITORS |
| 06/25/1998 | WO1998007449A3 Polymer bile acid resorption inhibitors with simultaneous bile acid adsorbing effect |
| 06/25/1998 | WO1998002151A3 Chemokine receptor antagonists and methods of use therefor |
| 06/25/1998 | CA2275507A1 Prebiotics and probiotics |
| 06/25/1998 | CA2274892A1 Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)-quinolone carboxylic acid and naphthyridone carboxylic acid derivatives for treating helicobacter pylori infections andthe gastroduodenal diseases associated therewith |
| 06/24/1998 | EP0849263A2 Pharmaceutical substituted propanoic acid derivatives |
| 06/24/1998 | EP0849256A1 Amide compounds and use of the same |
| 06/24/1998 | EP0848706A1 Substituted benzene-fused hetero- and carbocyclics as neurokinin antagonists |
| 06/24/1998 | EP0679161B1 Thiazolidine derivatives, preparation thereof and drugs containing same |
| 06/24/1998 | CN1185435A Sulfamide-substituted compound, preparation method, and medicinal preparation containing same |
| 06/24/1998 | CN1185335A Instant powder for curing hepatitis B |
| 06/24/1998 | CN1038840C Para-dinitrogen naphthalene derivative, its preparation method and medical use |
| 06/23/1998 | US5770735 Neurokinin receptor antagonists |
| 06/23/1998 | US5770611 Indole derivatives as 5HT1 -like agonists |
| 06/23/1998 | US5770586 Quaternary nitrogen-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism amd methods of treating and preventing dental calculus and plaque |
| 06/23/1998 | US5770570 Method of delivering a vasoactive intestinal polypeptide, an encapsulated vasoactive intestinal polypeptide, and a method of making the encapsulated vasoactive intestinal polypeptide |
| 06/23/1998 | US5770204 Composition for mucosa treatment with saponin |
| 06/23/1998 | US5770196 Modified antibody variable domains and therapeutic uses thereof |
| 06/23/1998 | CA2119636C Low ph aqueous cosmetic gel containing non-ionic polyacrylamide derivatives |
| 06/23/1998 | CA2096318C 8-chloro-11-[1-[(5-methyl-3-pyridyl)methyl]-4-piperidyliden]-6,11-dihydro-5h-benzo[5,6]cyclohepta[1,2-b]pyridine |
| 06/23/1998 | CA2008739C Compositions and method for the treatment of disease |
| 06/18/1998 | WO1998026069A1 Methods and compositions for identifying morphogen analogs |
| 06/18/1998 | WO1998026068A1 Human apoptosis-related calcium-binding protein |
| 06/18/1998 | WO1998026047A1 Methods and compositions for identifying morphogen analogs |
| 06/18/1998 | WO1998026043A1 Lactobacillus bifidus growth promoting composition and use thereof |
| 06/18/1998 | WO1998025971A1 Monovalent antibody fragments |
| 06/18/1998 | WO1998025911A1 1,5-benzodiazepine derivatives |
| 06/18/1998 | WO1998025901A1 Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them |
| 06/18/1998 | WO1998025875A1 ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO[1,2-g]-CHROM-3-ENE, BENZO[1,2-g]-THIOCHROM-3-ENE AND BENZO[1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY |
| 06/18/1998 | WO1998025637A1 Biomaterial derived from vertebrate liver tissue |
| 06/18/1998 | WO1998025629A1 Prophylactic and therapeutic agent for inflammatory intestinal diseases |
| 06/18/1998 | WO1998025619A1 Novel compounds |
| 06/18/1998 | WO1998025613A2 Galenic composition containing opioid antagonists |
| 06/18/1998 | WO1998025471A1 A method of biological control |
| 06/18/1998 | WO1998025470A1 A method of biological control |
| 06/18/1998 | DE19652239A1 Verwendung von 7-(2-Oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-chinolon- und -naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen Use of 7- (2-oxa-5,8-diazabicyclo [4.3.0] non-8-yl) -chinolon- -naphthyridoncarbonsäure and derivatives for the therapy of Helicobacter pylori infections and the gastroduodenal disorders associated therewith |
| 06/18/1998 | DE19652219A1 Verwendung von 7-(1-Aminomethyl-2-oxa-7-azabicyclo[3.3.0]oct-7-yl)-chinolon- und naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen Use of 7- (1-Aminomethyl-2-oxa-7-azabicyclo [3.3.0] oct-7-yl) -chinolon- and naphthyridonecarboxylic acid derivatives for the therapy of Helicobacter pylori infections and the gastroduodenal disorders associated therewith |
| 06/18/1998 | DE19651551A1 Opioidantagonisthaltige galenische Formulierung Opioid antagonist-containing pharmaceutical formulation |
| 06/18/1998 | CA2274898A1 Indolin-2-one derivatives, method for preparing them and pharmaceutical compositions containing them |
| 06/18/1998 | CA2274838A1 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo[1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity |
| 06/18/1998 | CA2274739A1 Human apoptosis-related calcium-binding protein |
| 06/18/1998 | CA2274655A1 Novel compounds |
| 06/17/1998 | EP0847996A1 Sulfonamide substituted compounds as K-channel blockers |
| 06/17/1998 | EP0847756A1 Plant extracts for the preparation of pharmaceutical compositions for the treatment of hepatitis |
| 06/17/1998 | EP0714389B1 Amide and urea derivatives as 5ht1d receptor antagonists |
| 06/17/1998 | CN1185178A Recombinant preduodenal lipases and polypeptide derivatives produced by plant, prodn. and use thereof |
| 06/17/1998 | CN1185107A Pharmaceutical composition contg. proton pump inhititors |
| 06/17/1998 | CN1184651A Medicine for treating stomach disease |
| 06/17/1998 | CN1184649A Traditional Chinese Medicine- |
| 06/17/1998 | CA2224835A1 Pharmaceutical compounds |
| 06/16/1998 | US5767116 Bicyclic aromatic compounds as therapeutic agents |
| 06/16/1998 | US5767088 Useful for treating pain, inflammation, smooth muscle contraction and inducing vasodilation |
| 06/16/1998 | US5767066 Medical application of bromelain |
| 06/16/1998 | US5766886 Modified antibody variable domains |
| 06/16/1998 | CA2224885A1 Sulfonamide-substituted compounds, processes for their preparation, their use as a medicament or diagnostic, and pharmaceutical preparations comprising them |
| 06/16/1998 | CA2165779C Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 06/16/1998 | CA2132831C Hydrazide derivatives of 3,4-dihydro-2h-1-benzopyrans |
| 06/16/1998 | CA1339917C New potically-active derivatives of (r) 5-pentylamino- 5- oxopentanoic acid with antagonistic activity towards cholecystokinin and a method for their preparation |
| 06/11/1998 | WO1998024914A1 Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy |
| 06/11/1998 | WO1998024905A2 Secreted proteins and polynucleotides encoding them |
| 06/11/1998 | WO1998024902A1 Adaptor protein frs2 and related products and methods |
| 06/11/1998 | WO1998024813A2 Keratinocyte growth factors and their use in combination with glucagon-like peptide derivatives |
| 06/11/1998 | WO1998024805A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 06/11/1998 | WO1998024794A1 PHENYL GLYOXAMIDES AS sPLA2 INHIBITORS |
| 06/11/1998 | WO1998024790A1 1,4-diazabicyclo [2.2.2] oct-2-ylmethyl derivatives, their preparation and therapeutic application |
| 06/11/1998 | WO1998024782A2 Substituted pyrimidine compounds and their use |
| 06/11/1998 | WO1998024780A2 Substituted pyrimidinone and pyridinone compounds and their use |
| 06/11/1998 | WO1998024771A1 Benzamide derivatives having a vasopressin antagonistic activity |
| 06/11/1998 | WO1998024766A1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors |
| 06/11/1998 | WO1998024473A1 Tissue fibrosis inhibitor |
| 06/11/1998 | WO1998024467A1 Remedies for fulminant hepatitis |
| 06/11/1998 | WO1998024465A1 Wound healing and treatment of fibrosis |
| 06/11/1998 | WO1998024437A1 Pyrazoles as human non-pancreatic secretory phospholipase a2 inhibitors |
| 06/11/1998 | WO1998024430A1 Pharmaceutical compositions containing n-sulphonyl indolin derivatives |
| 06/11/1998 | WO1998024427A2 Compositions and methods for treating or preventing inflammatory diseases |
| 06/11/1998 | CA2607067A1 Compositions and methods for treating or preventing inflammatory diseases |
| 06/11/1998 | CA2274249A1 Inhibitors of interleukin-1.beta. converting enzyme |
| 06/11/1998 | CA2274145A1 Adaptor protein frs2 and related products and methods |
| 06/11/1998 | CA2274048A1 Pyrazoles as human non-pancreatic secretory phospholipase a2 inhibitors |
| 06/11/1998 | CA2274019A1 Phenyl glyoxamides as spla2 inhibitors |
| 06/11/1998 | CA2274011A1 Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy |
| 06/11/1998 | CA2274002A1 Wound healing and treatment of fibrosis |
| 06/11/1998 | CA2273990A1 Pharmaceutical compositions containing n-sulphonyl indolin derivatives |
| 06/11/1998 | CA2273845A1 Secreted proteins and polynucleotides encoding them |
| 06/11/1998 | CA2271072A1 1,4-diazabicyclo [2.2.2] oct-2-ylmethyl derivatives, their preparation and therapeutic application |